Introduction
The treatment of septicaemia, especially when complicated by shock, has undergone marked changes in the last decade, but despite the introduction of many new therapeutic measures the mortality remains high (Melby and Spink, 1958 ; Gourzis et al., 1961 ; Blair et al., 1961 ; McCabe and Jackson, 1962; Bennett et al., 1963; Lillihei et al., 1964; Weil et al., 1964; Hodgin and Sanford, 1965 ; Maclean et al., 1965 ; du Toit et al., 1966; Kardos, 1966; Anderson et al., 1967; Siegel et al., 1967) .
In the present study a comparison of the mortality rates of patients with septicaemia in 1962-5 and in 1966-8 in a large general hospital shows a significant improvement in the survival of patients with Gram-negative infections and of those with shock, coinciding with a number of changes in the approach to treatment. The contribution of these changes to the reduction in mortality is analysed below.
Materials and Methods
This report is based on 173 patients in whom a clinical diagnosis of septicaemia was confirmed by a positive blood culture in the period 1 January 1962 to 30 April 1968. The clinical and laboratory data obtained from case records were correlated with mortality to assess the efficacy of the therapeutic measures used. Shock was arbitrarily defined as a reduction in systolic blood pressure to less than 90 mm. Hg or by more than 50 mm. Hg in a known hypertensive patient. These criteria for the diagnosis of shock were applied without change in -5 and 1966 -8. Treatment 1962 Antibiotics used in this period included tetracycline, chloramphenicol, erythromycin, streptomycin, and penicillin in * Clinical Superintendent (Medical). (Melby and Spink, 1958; Spink and Vick, 1961 ; McCabe and Jackson, 1962; Weil, 1962; Weil et al., 1964; Hodgin and Sanford, 1965) . The central venous pressure was monitored in patients with shock by means of a polyethylene catheter inserted through the antecubital vein, advanced into the chest, and then connected to a saline manometer (Smith and Moore, 1962; McGowan and Walters, 1963; Prout, 1968) . Frequent measurements of the central venous pressure were used to control fluid therapy so as to maintain the central venous pressure between 10 and 15 cm. of water relative to the mid-axillary line with the patient supine. Digitalis was given to patients in heart failure, and to those in whom fluid therapy raised the central venous pressure without restoration of systemic arterial blood pressure. In cases where hypotension and a raised central venous pressure persisted a beta-adrenergic stimulator such as isoprenaline was given.
Results

Clinical Data
The clinical features of septicaemia observed in this series were typical of those reported by other authors and will not be dwelt on here (Hassall and Rountree, 1959; McCabe and Jackson, 1962 ; McHenry et al., 1962 ; Waisbren, 1964 ; Weil et al., 1964; Hodgin and Sanford, 1965) . There were 61 patients with septicaemia in 1962-5 and 112 in 1966-8 . These two groups of patients were similar with respect to age, sex, underlying conditions, contributory factors, and results of laboratory tests (Table I ). The investigations done in all patients included a haemoglobin, full blood count, blood urea, serum electrolytes, chest x-ray examination, and electrocardiogram. The results of these were quite unremarkable and they are not shown in full.
Mortality
The mortality rate in 1962-5 was 43% and in 1966-8 it was only 28% (Table II) . The improvement in survival was limited to two groups of patients, those with Gram-negative infections and those with shock. Tables III and IV do not tally exactly owing to the presence of eight patients in whom more than one organism was grown from the blood stream (" Multiple," Table III) .
t Kanamycin was not used in 1962-5 and is therefore based on smaller numbers than shown in column 2. In-vitro sensitivity of Ps. aeruginosa to kanamycin was not routinely assessed.
Mortality Correlated With Therapy
Antibiotics.-The efficacy of the antibiotics used has been assessed by examining the results for Gram-negative infections, for staphylococcal infections, and for the whole series. While antibiotics are essential in the treatment of patients with septicaemia and were used in all cases, there were no significant differences in the mortality rates of patients treated with different antibiotics (Table V) . (Thomas, 1956 ; Zweifach et al., 1956; Gilbert, 1960 ; Weil and Miller, 1961 ; Spink, 1962; Lillehei et al., 1964 ; Waisbren, 1964 ; Weil et al., 1964;  Udhoji and Weil, 1965 (Maclean et al., 1965 ; Siegel et al., 1967) . Siegel et al. (1967) Anderson, 1954; Thomas, 1956; Spink and Vick, 1961 and Miller, 1961 ; Spink, 1962 Weil, 1962 Lillihei al., 1964; Waisbren, 1964 (Waisbren, 1964 (Waisbren, et al., 1964 Cavanagh and McLeod, 1966 BRITISH 341
were available and had to cover a wide range of possible microorganisms, whereas other antibiotics were usually used only if sensitivity tests indicated they were appropriate. Therefore the fact that the mortality with kanamycin was the same as with other antibiotics suggests that the broad cover it affords in vitro is matched by efficacy in the patient, especially in Gramnegative infections. Once the results of blood cultures and sensitivity tests are at hand a charge of antibiotics is necessary in only a small percentage of infections, including those due to Ps. aeruginosa, which is probily best treated with carbenicillin (Jones and Lowbury, 1967; Knudsen et al., 1967; Stratford, 1968) , and those due to Gram-positive cocci other than staphylococci. Of these, pneumococci and beta-haemolytic streptococci require high dosage of penicillin, which should be added to the initial antibiotic therapy whenever an infection due to one of these organisms is suspected. Str. faecalis will usually respond to ampicillin. The failure to reduce the high mortality in staphylococcal septicaemia probably stems from two factors. Firstly, the diagnosis is often delayed, perhaps because shock is not very common and occurs late. Secondly, there was usually no specific antibiotic therapy against the staphylococcus in the current series until the culture results were known. While kanamycin did provide in-vitro cover against Staph. aureus in 92 % of the present cases, it may not be as effective in vivo, and since May 1968 methicillin has been combined with kanamycin for the initial antibiotic therapy of suspected septicaemia pending -the results of blood cultures. Recent reports of increasing incidence of methicillin-resistant staphylococci (Benner and Kayser, 1968 ; Rountree and Beard, 1969) suggest that staphylococcal septicemia will continue to present a therapeutic problem.
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